The mythbuster: Buying ‘innovative’ drugs is not the best use of NHS funds (HSJ, 23 December 2024)

Summary

Rising drug costs strain NHS budgets, yet many new medicines deliver fewer health benefits than alternative interventions. A Lancet study underscores the need to reassess spending priorities and tackle inefficiencies in resource allocation for better patient outcomes, writes Steve Black in this HSJ article.